GT Biopharma (GTBP) Gross Profit (2010 - 2015)
GT Biopharma (GTBP) posted quarterly Gross Profit of $20000.0 for Q2 2015, up 185.71% quarter-over-quarter from $7000.0 in Q1 2015.
GT Biopharma (GTBP) Gross Profit (2010 - 2015) Analysis & Trends
GT Biopharma (GTBP) has reported Gross Profit for 5 consecutive years, with $20000.0 the latest figure, recorded in Q2 2015.
- In Q2 2015, Gross Profit changed N/A year-over-year to $20000.0; the TTM figure through Mar 2016 stood at $20000.0 (down 89.13% YoY), while the FY2015 annual figure was $27000.0, up 575.0% from the prior year.
- Gross Profit advanced to $20000.0 in Q2 2015 per GTBP's latest filing, from $7000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $158000.0 in Q4 2012 and bottomed at -$14000.0 in Q2 2011.
- Historically, Gross Profit has averaged $27100.0 across 4 years, with a median of $5000.0 in 2011.
- Annual changes were most pronounced in 2011 — Gross Profit soared 105.56% — and 2012, when it surged 5166.67%.
- GT Biopharma's Gross Profit stood at $3000.0 in 2011, then soared by 5166.67% to $158000.0 in 2012, then tumbled by 87.97% to $19000.0 in 2013, then gained by 5.26% to $20000.0 in 2015.
- Business Quant data shows GTBP's Gross Profit at $20000.0 in Q2 2015, $7000.0 in Q1 2015, and $19000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 20,000.00 |
| Jun 30, 2015 | 20,000.00 |
| Mar 31, 2015 | 7,000.00 |
| Mar 31, 2015 | 7,000.00 |
| Mar 31, 2013 | 19,000.00 |
| Mar 31, 2013 | 19,000.00 |
| Dec 31, 2012 | 158,000.00 |
| Dec 31, 2012 | 158,000.00 |
| Sep 30, 2012 | 88,000.00 |
| Sep 30, 2012 | 88,000.00 |
| Jun 30, 2012 | 1,000.00 |
| Jun 30, 2012 | 1,000.00 |
| Dec 31, 2011 | 3,000.00 |
| Dec 31, 2011 | 3,000.00 |
| Sep 30, 2011 | -6,000.00 |
| Sep 30, 2011 | -6,000.00 |
| Jun 30, 2011 | -14,000.00 |
| Jun 30, 2011 | -14,000.00 |
| Mar 31, 2011 | -5,000.00 |
| Mar 31, 2011 | -5,000.00 |